Post-polio Syndrome Clinical Trial
Official title:
Quantitative Spinal Cord Gray Matter Imaging in Post Polio Syndrome
This is a longitudinal, observational study with the aims of comparing spinal cord gray matter areas in patients with Post-Polio Syndrome to age and sex matched healthy control subjects and to correlate atrophy with metrics of clinical disability.
Post-Polio syndrome (PPS) is characterised by new muscle weakness, pain, and fatigue several
years to decades after the acute polio infection. Pathomechanisms are not yet fully
understood.
This is a longitudinal, observational study. The aims are (a) to detect spinal cord gray (and
possibly) white matter atrophy in patients with Post Polio Syndrome in comparison to healthy
age and sex matched control subjects both cross-sectionally and longitudinally and (b) to
correlate spinal cord gray and white matter atrophy to metrics of clinical disability.
Investigators will assess 20 patients with Post-Polio syndrome and 20 control subjects at
baseline and 48 weeks by MRI and clinically including quantitative muscle strength
assessments.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT02176863 -
Study of the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% DIF in Patients With Post-polio Syndrome
|
Phase 2/Phase 3 | |
Completed |
NCT02815878 -
Enhance Wellness for Individuals With Long-Term Physical Disabilities
|
N/A | |
Recruiting |
NCT05644522 -
Nomad P-KAFO Study
|
N/A | |
Completed |
NCT02801071 -
L-Citrulline in Patients With Post-Polio Syndrome
|
Phase 3 | |
Completed |
NCT03064711 -
Activity and Fatigue of the Respiratory Muscles and Pulmonary Characteristics in Post-Polio Patients
|
N/A | |
Completed |
NCT01537575 -
Intravenous Immunoglobulins for Post-Polio Syndrome
|
Phase 3 | |
Active, not recruiting |
NCT02089880 -
Comparing Functional Outcomes in Individuals Using Micro-processor Controlled Orthosis Versus Stance Control Orthosis
|
N/A | |
Completed |
NCT01402570 -
Glutathione and Health With Post-Polio Syndrome
|
N/A | |
Completed |
NCT00231439 -
Post-Poliosyndrome Treated With Intravenous Immunoglobulin (IvIg)
|
Phase 2/Phase 3 |